Antiretrovirals

DRUG5 trials

Sponsors

University Hospital, Strasbourg, France, Aarhus University Hospital, University of California, San Francisco, University of California, Los Angeles, Code Pharma

Conditions

HIVHIV InfectionHIV InfectionsHivHuman Immunodeficiency VirusOsteopeniaOsteoporosis

Phase 2

Early Administration of Romidepsin and 3BNC117 in Treatment-naïve HIV Patients Starting ART

CompletedNCT03041012

Aarhus University HospitalHiv

Start: 2017-01-20End: 2022-12-30Updated: 2025-04-18

Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants

RecruitingNCT06676410

Code PharmaHIV, HIV Infection

Start: 2023-07-20End: 2024-12-31Target: 40Updated: 2024-11-06

Unknown Phase

Bone Mineral Density (BMD) in HIV Infection

TerminatedNCT00146094

University Hospital, Strasbourg, FranceOsteopenia, Osteoporosis

Start: 2003-03-31End: 2006-12-14Updated: 2025-09-26

The Impact and Cost-effectiveness of Safer Conception Strategies for HIV-discordant Couples (SAFER)

CompletedNCT03049176

University of California, San FranciscoHIV Infections

Start: 2017-03-13End: 2019-07-31Updated: 2019-09-30

Prevention and Treatment Continuum for Youth at HIV Risk, Acutely Infected and With Established HIV Infection

CompletedNCT03205696

University of California, Los AngelesHuman Immunodeficiency Virus

Start: 2017-08-01End: 2023-11-30Updated: 2025-03-25

Related Papers

Preventing HIV and achieving pregnancy among HIV sero-different couples: Pilot study of a safer conception intervention in Zimbabwe

PLOS Global Public Health2023-02-2410 citations

Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial.

2022-10-17102 citations

Estimated costs for the delivery of safer conception strategies for HIV-discordant couples in Zimbabwe: a cost analysis.

2020-10-127 citations